LPI (LP Information)' newest research report, the “Disease Registry Software Industry Forecast” looks at past sales and reviews total world Disease Registry Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Disease Registry Software sales for 2023 through 2029. With Disease Registry Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Disease Registry Software industry.
This Insight Report provides a comprehensive analysis of the global Disease Registry Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Disease Registry Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Disease Registry Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Disease Registry Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Disease Registry Software.
The global Disease Registry Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Disease Registry Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Disease Registry Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Disease Registry Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Disease Registry Software players cover ARMUS, AltaVoice, ArborMetrix Inc, CECity.com, CEDARON, Dacima Software, EVADO, FIGmd and GZ Software, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Disease Registry Software market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Integrated
Standalone
Segmentation by application
Hospital
Clinic
Nursing Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ARMUS
AltaVoice
ArborMetrix Inc
CECity.com
CEDARON
Dacima Software
EVADO
FIGmd
GZ Software
Global Vision Technologies
HealthDiary
Healthmonix
Ifa systems
ImageTrend
IBM
Liaison Technologies
Lumedx
M2S
McKesson Corporation
Optum

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Disease Registry Software Market Size 2018-2029 2.1.2 Disease Registry Software Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Disease Registry Software Segment by Type 2.2.1 Integrated 2.2.2 Standalone 2.3 Disease Registry Software Market Size by Type 2.3.1 Disease Registry Software Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Disease Registry Software Market Size Market Share by Type (2018-2023) 2.4 Disease Registry Software Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Nursing Center 2.4.4 Others 2.5 Disease Registry Software Market Size by Application 2.5.1 Disease Registry Software Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Disease Registry Software Market Size Market Share by Application (2018-2023) 3 Disease Registry Software Market Size by Player 3.1 Disease Registry Software Market Size Market Share by Players 3.1.1 Global Disease Registry Software Revenue by Players (2018-2023) 3.1.2 Global Disease Registry Software Revenue Market Share by Players (2018-2023) 3.2 Global Disease Registry Software Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Disease Registry Software by Regions 4.1 Disease Registry Software Market Size by Regions (2018-2023) 4.2 Americas Disease Registry Software Market Size Growth (2018-2023) 4.3 APAC Disease Registry Software Market Size Growth (2018-2023) 4.4 Europe Disease Registry Software Market Size Growth (2018-2023) 4.5 Middle East & Africa Disease Registry Software Market Size Growth (2018-2023) 5 Americas 5.1 Americas Disease Registry Software Market Size by Country (2018-2023) 5.2 Americas Disease Registry Software Market Size by Type (2018-2023) 5.3 Americas Disease Registry Software Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Disease Registry Software Market Size by Region (2018-2023) 6.2 APAC Disease Registry Software Market Size by Type (2018-2023) 6.3 APAC Disease Registry Software Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Disease Registry Software by Country (2018-2023) 7.2 Europe Disease Registry Software Market Size by Type (2018-2023) 7.3 Europe Disease Registry Software Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Disease Registry Software by Region (2018-2023) 8.2 Middle East & Africa Disease Registry Software Market Size by Type (2018-2023) 8.3 Middle East & Africa Disease Registry Software Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Disease Registry Software Market Forecast 10.1 Global Disease Registry Software Forecast by Regions (2024-2029) 10.1.1 Global Disease Registry Software Forecast by Regions (2024-2029) 10.1.2 Americas Disease Registry Software Forecast 10.1.3 APAC Disease Registry Software Forecast 10.1.4 Europe Disease Registry Software Forecast 10.1.5 Middle East & Africa Disease Registry Software Forecast 10.2 Americas Disease Registry Software Forecast by Country (2024-2029) 10.2.1 United States Disease Registry Software Market Forecast 10.2.2 Canada Disease Registry Software Market Forecast 10.2.3 Mexico Disease Registry Software Market Forecast 10.2.4 Brazil Disease Registry Software Market Forecast 10.3 APAC Disease Registry Software Forecast by Region (2024-2029) 10.3.1 China Disease Registry Software Market Forecast 10.3.2 Japan Disease Registry Software Market Forecast 10.3.3 Korea Disease Registry Software Market Forecast 10.3.4 Southeast Asia Disease Registry Software Market Forecast 10.3.5 India Disease Registry Software Market Forecast 10.3.6 Australia Disease Registry Software Market Forecast 10.4 Europe Disease Registry Software Forecast by Country (2024-2029) 10.4.1 Germany Disease Registry Software Market Forecast 10.4.2 France Disease Registry Software Market Forecast 10.4.3 UK Disease Registry Software Market Forecast 10.4.4 Italy Disease Registry Software Market Forecast 10.4.5 Russia Disease Registry Software Market Forecast 10.5 Middle East & Africa Disease Registry Software Forecast by Region (2024-2029) 10.5.1 Egypt Disease Registry Software Market Forecast 10.5.2 South Africa Disease Registry Software Market Forecast 10.5.3 Israel Disease Registry Software Market Forecast 10.5.4 Turkey Disease Registry Software Market Forecast 10.5.5 GCC Countries Disease Registry Software Market Forecast 10.6 Global Disease Registry Software Forecast by Type (2024-2029) 10.7 Global Disease Registry Software Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 ARMUS 11.1.1 ARMUS Company Information 11.1.2 ARMUS Disease Registry Software Product Offered 11.1.3 ARMUS Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 ARMUS Main Business Overview 11.1.5 ARMUS Latest Developments 11.2 AltaVoice 11.2.1 AltaVoice Company Information 11.2.2 AltaVoice Disease Registry Software Product Offered 11.2.3 AltaVoice Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 AltaVoice Main Business Overview 11.2.5 AltaVoice Latest Developments 11.3 ArborMetrix Inc 11.3.1 ArborMetrix Inc Company Information 11.3.2 ArborMetrix Inc Disease Registry Software Product Offered 11.3.3 ArborMetrix Inc Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 ArborMetrix Inc Main Business Overview 11.3.5 ArborMetrix Inc Latest Developments 11.4 CECity.com 11.4.1 CECity.com Company Information 11.4.2 CECity.com Disease Registry Software Product Offered 11.4.3 CECity.com Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 CECity.com Main Business Overview 11.4.5 CECity.com Latest Developments 11.5 CEDARON 11.5.1 CEDARON Company Information 11.5.2 CEDARON Disease Registry Software Product Offered 11.5.3 CEDARON Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 CEDARON Main Business Overview 11.5.5 CEDARON Latest Developments 11.6 Dacima Software 11.6.1 Dacima Software Company Information 11.6.2 Dacima Software Disease Registry Software Product Offered 11.6.3 Dacima Software Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Dacima Software Main Business Overview 11.6.5 Dacima Software Latest Developments 11.7 EVADO 11.7.1 EVADO Company Information 11.7.2 EVADO Disease Registry Software Product Offered 11.7.3 EVADO Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 EVADO Main Business Overview 11.7.5 EVADO Latest Developments 11.8 FIGmd 11.8.1 FIGmd Company Information 11.8.2 FIGmd Disease Registry Software Product Offered 11.8.3 FIGmd Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 FIGmd Main Business Overview 11.8.5 FIGmd Latest Developments 11.9 GZ Software 11.9.1 GZ Software Company Information 11.9.2 GZ Software Disease Registry Software Product Offered 11.9.3 GZ Software Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 GZ Software Main Business Overview 11.9.5 GZ Software Latest Developments 11.10 Global Vision Technologies 11.10.1 Global Vision Technologies Company Information 11.10.2 Global Vision Technologies Disease Registry Software Product Offered 11.10.3 Global Vision Technologies Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Global Vision Technologies Main Business Overview 11.10.5 Global Vision Technologies Latest Developments 11.11 HealthDiary 11.11.1 HealthDiary Company Information 11.11.2 HealthDiary Disease Registry Software Product Offered 11.11.3 HealthDiary Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 HealthDiary Main Business Overview 11.11.5 HealthDiary Latest Developments 11.12 Healthmonix 11.12.1 Healthmonix Company Information 11.12.2 Healthmonix Disease Registry Software Product Offered 11.12.3 Healthmonix Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Healthmonix Main Business Overview 11.12.5 Healthmonix Latest Developments 11.13 Ifa systems 11.13.1 Ifa systems Company Information 11.13.2 Ifa systems Disease Registry Software Product Offered 11.13.3 Ifa systems Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Ifa systems Main Business Overview 11.13.5 Ifa systems Latest Developments 11.14 ImageTrend 11.14.1 ImageTrend Company Information 11.14.2 ImageTrend Disease Registry Software Product Offered 11.14.3 ImageTrend Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 ImageTrend Main Business Overview 11.14.5 ImageTrend Latest Developments 11.15 IBM 11.15.1 IBM Company Information 11.15.2 IBM Disease Registry Software Product Offered 11.15.3 IBM Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 IBM Main Business Overview 11.15.5 IBM Latest Developments 11.16 Liaison Technologies 11.16.1 Liaison Technologies Company Information 11.16.2 Liaison Technologies Disease Registry Software Product Offered 11.16.3 Liaison Technologies Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Liaison Technologies Main Business Overview 11.16.5 Liaison Technologies Latest Developments 11.17 Lumedx 11.17.1 Lumedx Company Information 11.17.2 Lumedx Disease Registry Software Product Offered 11.17.3 Lumedx Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 Lumedx Main Business Overview 11.17.5 Lumedx Latest Developments 11.18 M2S 11.18.1 M2S Company Information 11.18.2 M2S Disease Registry Software Product Offered 11.18.3 M2S Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 M2S Main Business Overview 11.18.5 M2S Latest Developments 11.19 McKesson Corporation 11.19.1 McKesson Corporation Company Information 11.19.2 McKesson Corporation Disease Registry Software Product Offered 11.19.3 McKesson Corporation Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 McKesson Corporation Main Business Overview 11.19.5 McKesson Corporation Latest Developments 11.20 Optum 11.20.1 Optum Company Information 11.20.2 Optum Disease Registry Software Product Offered 11.20.3 Optum Disease Registry Software Revenue, Gross Margin and Market Share (2018-2023) 11.20.4 Optum Main Business Overview 11.20.5 Optum Latest Developments 12 Research Findings and Conclusion